Pathogenesis of Atopic Dermatitis
Pathogenesis of Atopic Dermatitis
批准号:
7134865
负责人:
MARK H KAPLAN
金额:
$99.14万
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-06-15 至 2011-05-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant):
Atopic dermatitis (AD) is a common allergic disease seen in 10-20% of infants. While severity often
diminishes with age, AD can persist throughout life. Moreover, AD severity can be a predictor of
subsequent allergic disease as 60% of children who have AD will develop other atopic diseases, including
asthma. Thus, it is often thought that AD is the first step on the "Allergic March" towards more severe atopic
disease. While both defects in skin and a predisposition towards a hyper-Th2 response contribute towards
AD, it is not clear which is the primary defect in the pathogenesis of AD. Chronic lesions convert to
inflammation more characteristic of Th1-mediated immunity though what triggers this switch is unclear. In
this AADCRC application, we will define several of the factors that contribute to disease initiation and
exacerbation. In Project 1, patient samples and a mouse model of AD resulting from hyper-Th2 responses
will be used to determine which cytokine and signaling pathways correlate with, or are required for, AD
development. The mouse model of AD will also be used to define the effects of AD concurrent with the
development of other atopic diseases. Project 2 will examine the contribution of dendritic cells as mediators
of innate immunity in the development of AD by examining the function of DC populations in patient samples
and mice that have AD and their ability to direct either Th2 or Th1 dependent immunity. Project 3 will
qualitatively and quantitatively define bacteria and bacterial products from infected AD lesions. The role of
the lipid mediator platelet-activating factor (PAF) and toll-like receptors in bacterial product-mediated
inflammation and immunomodulation will be assessed both in vitro as well as in vivo using cellular and
murine models. These three projects, supported by an Administrative and Resources Cores, are highly
interactive and interrelated. The focus of this application, coupled with the complementary backgrounds of
each of the Project Directors, provide a scientific environment poised to make rapid progress in defining the
roles of immune components in Atopic Dermatitis.
Lay summary-Atopic dermatitis is a very common allergic disorder affecting 10-20% of infants. While it is
not a life-threatening disease, it is a source of great discomfort and can have adverse effects on social and
emotional development. Additionally, it is a strong indication for the development of other allergic diseases
later in life, including asthma. This proposal examines the development of atopic dermatitis and how
development may impact other allergic diseases.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Defining a type II IL-9R
-
批准号:10739086
-
项目类别:
-
资助金额:$23.78万
-
财政年份:2023
-
负责人:MARK H KAPLAN
-
依托单位:
IL-9-dependent interstitial macrophage function in the allergic lung
-
批准号:10741356
-
项目类别:
-
资助金额:$46.11万
-
财政年份:2017
-
负责人:MARK H KAPLAN
-
依托单位:
Th9 cells in immediate hypersensitivity
-
批准号:10083170
-
项目类别:
-
资助金额:$39.38万
-
财政年份:2017
-
负责人:MARK H KAPLAN
-
依托单位:
Th9 cells in immediate hypersensitivity
-
批准号:9257791
-
项目类别:
-
资助金额:$39.19万
-
财政年份:2017
-
负责人:MARK H KAPLAN
-
依托单位:
Granzyme A-secreting T cells in allergic inflammation
-
批准号:8869766
-
项目类别:
-
资助金额:$19.5万
-
财政年份:2015
-
负责人:MARK H KAPLAN
-
依托单位:
Cytokine regulation of skin barrier function
-
批准号:8292335
-
项目类别:
-
资助金额:$38.5万
-
财政年份:2012
-
负责人:MARK H KAPLAN
-
依托单位:
STAT3 in T helper cell development
-
批准号:8461515
-
项目类别:
-
资助金额:$7.8万
-
财政年份:2012
-
负责人:MARK H KAPLAN
-
依托单位:
STAT3 in T helper cell development
-
批准号:8354840
-
项目类别:
-
资助金额:$7.79万
-
财政年份:2012
-
负责人:MARK H KAPLAN
-
依托单位:
Cytokine regulation of skin barrier function
-
批准号:8420261
-
项目类别:
-
资助金额:$36.66万
-
财政年份:2012
-
负责人:MARK H KAPLAN
-
依托单位:
Cytokine regulation of skin barrier function
-
批准号:8603836
-
项目类别:
-
资助金额:$39.0万
-
财政年份:2012
-
负责人:MARK H KAPLAN
-
依托单位:
Cytokine regulation of skin barrier function
-
批准号:8996670
-
项目类别:
-
资助金额:$39.0万
-
财政年份:2012
-
负责人:MARK H KAPLAN
-
依托单位:
Cytokine regulation of skin barrier function
-
批准号:10329971
-
项目类别:
-
资助金额:$47.72万
-
财政年份:2012
-
负责人:MARK H KAPLAN
-
依托单位:
PARP activity in allergic inflammation
-
批准号:8300859
-
项目类别:
-
资助金额:$38.12万
-
财政年份:2009
-
负责人:MARK H KAPLAN
-
依托单位:
Administration Core
-
批准号:7150326
-
项目类别:
-
资助金额:$11.66万
-
财政年份:2006
-
负责人:MARK H KAPLAN
-
依托单位:
Resources Core
-
批准号:7150328
-
项目类别:
-
资助金额:$17.25万
-
财政年份:2006
-
负责人:MARK H KAPLAN
-
依托单位:
Pathogenesis of Atopic Dermatitis
-
批准号:7436176
-
项目类别:
-
资助金额:$95.58万
-
财政年份:2006
-
负责人:MARK H KAPLAN
-
依托单位:
Stat6 in Atopic Dermatitis
-
批准号:7150323
-
项目类别:
-
资助金额:$23.41万
-
财政年份:2006
-
负责人:MARK H KAPLAN
-
依托单位:
Pathogenesis of Atopic Dermatitis
-
批准号:7645661
-
项目类别:
-
资助金额:$98.44万
-
财政年份:2006
-
负责人:MARK H KAPLAN
-
依托单位:
Pathogenesis of Atopic Dermatitis
-
批准号:7862624
-
项目类别:
-
资助金额:$100.38万
-
财政年份:2006
-
负责人:MARK H KAPLAN
-
依托单位:
Pathogenesis of Atopic Dermatitis
-
批准号:7245885
-
项目类别:
-
资助金额:$94.94万
-
财政年份:2006
-
负责人:MARK H KAPLAN
-
依托单位:
海外基金